Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy
This review aims to present and discuss the current clinical and scientific data pertaining to lipid-lowering interventions targeting PCSK9.